Porter Novelli, EVC Group support biopharma merger

VANCOUVER: Porter Novelli is providing media and investor relations and internal communications for OncoGeneX Technologies, a biopharmaceutical company, which is merging with Sonus Pharmaceuticals. PN has been AOR for OncoGeneX since 2004. In addition, EVC Group of San Francisco is providing investor relations for Bothell, WA-based Sonus.

VANCOUVER: Porter Novelli is providing media and investor relations and internal communications for OncoGeneX Technologies, a biopharmaceutical company, which is merging with Sonus Pharmaceuticals. PN has been AOR for OncoGeneX since 2004. In addition, EVC Group of San Francisco is providing investor relations for Bothell, WA-based Sonus.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in